00481nas a2200181   4500000000100000000000100001008004100002100001500043700001400058700001700072700001500089700001200104700001600116245013600132300001000268490000700278022001400285       2015                            d1 aM. Warnier1 aF. Rutten1 aP. Souverein1 aA. de Boer1 aA. Hoes1 aM. De Bruin00aAre ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol  a701-80 v24  a1053-8569